United Therapeutics (UTHR) Tops Q3 EPS by $1.36, Revenues Beat

October 30, 2019 6:12 AM

United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.83, $1.36 better than the analyst estimate of $2.47. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found